Catalyst Pharmaceuticals-Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates

Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of$ 0.49 per share. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.33%. A quarter ago, it was expected that this specialty drug company would post earnings of$ 0.42 per share when it actually produced earnings of $0.56, delivering a surprise of 33.33%.Over the last four qua ...